Although hair loss does not typically result in physical harm, it may have significant psychosocial consequences, affecting self-esteem, quality of life, and adherence to treatment. On the reasons why people may suffer hair loss while on the drugs, the team said the most likely mechanism relates to weight loss and reduced caloric intake, though more research is needed
The results were good but more modest, a mean weight reduction of 9.6 percent with semaglutide 2.4 mg versus 3.4 percent with placebo at 68 weeks
5-amino-1MQ, along with other methylquinolinium-based compounds, is currently being investigated in laboratory studies for its potential effects on metabolic processes
Forbes NS, Coffin RS, Deng L, Evgin L, Fiering S, Giacalone M, et al
Frequently Asked Questions about Tesamorelin Everything you need to know about the FDA-approved GHRH analog of reference in metabolic research What is Tesamoreline